Huapont Life Sciences Co., Ltd. (002004.SZ)
CNY 4.64
(-1.28%)
CNY 4.64
(-1.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.59 Billion | 13.23 Billion | 12.35 Billion | 10.87 Billion | 10.09 Billion | 10.57 Billion |
| Cost of Revenue | 7.2 Billion | 7.87 Billion | 7.6 Billion | 6.42 Billion | 5.39 Billion | 6.28 Billion |
| Gross Profit | 4.38 Billion | 5.35 Billion | 4.75 Billion | 4.45 Billion | 4.69 Billion | 4.29 Billion |
| Operating Expenses | 3.46 Billion | 3.35 Billion | 3.13 Billion | 2.89 Billion | 3.1 Billion | 2.86 Billion |
| Selling, General and Administrative Expenses | 1.73 Billion | 2.04 Billion | 2.01 Billion | 1.97 Billion | 2.17 Billion | 1.88 Billion |
| Research and Development Expenses | 419.13 Million | 385.23 Million | 329.47 Million | 324.35 Million | 288.02 Million | 349.46 Million |
| Other Expenses | 1.3 Billion | 921.73 Million | 784.37 Million | 599.35 Million | 646.41 Million | 635.98 Million |
| Cost and Expenses | 10.66 Billion | 11.22 Billion | 10.73 Billion | 9.31 Billion | 8.5 Billion | 9.14 Billion |
| Operating Income | 926.51 Million | 2.65 Billion | 1.89 Billion | 1.74 Billion | 1.83 Billion | 1.77 Billion |
| Interest Expense | 343.69 Million | 434.01 Million | 461.67 Million | 561.07 Million | 565.44 Million | 605.02 Million |
| Income Tax Expense | 215.45 Million | 495.95 Million | 361.04 Million | 270.07 Million | 217.44 Million | 251.28 Million |
| Earnings before Tax | 892.38 Million | 1.62 Billion | 1.28 Billion | 1.16 Billion | 1.14 Billion | 1.07 Billion |
| Net Income | 302.12 Million | 1.12 Billion | 924.96 Million | 895 Million | 931.9 Million | 822.81 Million |
| Earnings Per Share Basic | 0.15 | 0.57 | 0.47 | 0.45 | 0.47 | 0.41 |
| Earnings Per Share Diluted | 0.15 | 0.57 | 0.47 | 0.45 | 0.47 | 0.41 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 2 Billion | 2.02 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 2 Billion | 2.02 Billion |
| Gross Margin | 0.38 | 0.40 | 0.38 | 0.41 | 0.47 | 0.41 |
| EBIT Margin | 0.18 | 0.26 | 0.21 | 0.22 | 0.24 | 0.22 |
| Profit Margin | 0.03 | 0.09 | 0.07 | 0.08 | 0.09 | 0.08 |
| EBITDA | 2.12 Billion | 2.85 Billion | 2.49 Billion | 2.42 Billion | 2.32 Billion | 2.29 Billion |
| Earnings Before Tax Margin | 0.08 | 0.20 | 0.15 | 0.16 | 0.18 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.98 Billion | 3 Billion | 2.91 Billion | 2.74 Billion | 11.59 Billion | 2.98 Billion |
| Cost of Revenue | 1.88 Billion | 1.88 Billion | 1.85 Billion | 1.78 Billion | 7.05 Billion | 1.85 Billion |
| Gross Profit | 1.1 Billion | 1.11 Billion | 1.05 Billion | 955.99 Million | 4.53 Billion | 1.13 Billion |
| Operating Expenses | 745.76 Million | 744.86 Million | 703.14 Million | 683.31 Million | 3.03 Billion | 785.95 Million |
| Selling, General and Administrative Expenses | 1.13 Billion | 242.82 Million | 589.99 Million | -241.12 Million | - | 1.03 Billion |
| Research and Development Expenses | 111.41 Million | 95.77 Million | 94.52 Million | 93.3 Million | - | 114.67 Million |
| Other Expenses | -499.94 Million | -6.53 Million | -2.19 Million | -16.77 Million | -34.12 Million | 2.39 Million |
| Cost and Expenses | 2.62 Billion | 2.63 Billion | 2.56 Billion | 2.46 Billion | 10.09 Billion | 2.63 Billion |
| Operating Income | 221.74 Million | 276.56 Million | 285.77 Million | -192.06 Million | 926.51 Million | 308.82 Million |
| Interest Expense | 86.36 Million | 90.25 Million | 87.22 Million | 93.79 Million | 343.69 Million | 76.98 Million |
| Income Tax Expense | 53.31 Million | 60.86 Million | 69.14 Million | -10.62 Million | 215.45 Million | 77.25 Million |
| Earnings before Tax | 214.22 Million | 270.64 Million | 283.57 Million | -208.83 Million | 892.38 Million | 305.99 Million |
| Net Income | 138.45 Million | 157.96 Million | 155.55 Million | -202.8 Million | 302.12 Million | 117.78 Million |
| Earnings Per Share Basic | 0.07 | 0.08 | 0.08 | -0.10 | - | 0.06 |
| Earnings Per Share Diluted | 0.07 | 0.08 | 0.08 | -0.10 | - | 0.06 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion |
| Gross Margin | 0.37 | 0.37 | 0.36 | 0.35 | 0.39 | 0.38 |
| EBIT Margin | 0.10 | 0.12 | 0.13 | 0.09 | - | 0.13 |
| Profit Margin | 0.05 | 0.05 | 0.05 | -0.07 | 0.03 | 0.04 |
| EBITDA | 300.58 Million | 374.31 Million | 369.65 Million | 252.62 Million | - | 377.06 Million |
| Earnings Before Tax Margin | 0.07 | 0.09 | 0.10 | -0.07 | 0.08 | 0.10 |
MAGE
FMNL
IVR
SHAH
QCKSF
VICO